| Literature DB >> 22727315 |
Stuart J Lansdell1, Toby Collins, Jim Goodchild, Neil S Millar.
Abstract
BACKGROUND: Nicotinic acetylcholine receptors (nAChRs) play an important role as excitatory neurotransmitters in vertebrate and invertebrate species. In insects, nAChRs are the site of action of commercially important insecticides and, as a consequence, there is considerable interest in examining their functional properties. However, problems have been encountered in the successful functional expression of insect nAChRs, although a number of strategies have been developed in an attempt to overcome such difficulties. Ten nAChR subunits have been identified in the model insect Drosophila melanogaster (Dα1-Dα7 and Dβ1-Dβ3) and a similar number have been identified in other insect species. The focus of the present study is the Dα5, Dα6 and Dα7 subunits, which are distinguished by their sequence similarity to one another and also by their close similarity to the vertebrate α7 nAChR subunit.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22727315 PMCID: PMC3444433 DOI: 10.1186/1471-2202-13-73
Source DB: PubMed Journal: BMC Neurosci ISSN: 1471-2202 Impact factor: 3.288
Radioligand binding to nAChR subunit combinations
| | ||||
| Dα5 | – | – | – | – |
| Dα5/Dα1 | – | – | – | – |
| Dα5/Dα2 | – | – | – | – |
| Dα5/Dα3 | – | – | – | – |
| Dα5/Dα4 | – | – | – | – |
| Dα5/Dα6 | – | + | – | – |
| Dα5/Dα7 | – | – | – | – |
| Dα5/Dβ1 | – | – | – | – |
| Dα5/Dβ2 | – | – | – | – |
| Dα5/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα2 | – | – | – | – |
| Dα5/Dα1/Dβ1 | – | – | – | – |
| Dα5/Dα1/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dβ3 | – | – | – | – |
| Dα5/Dα2/Dβ1 | – | – | – | – |
| Dα5/Dα2/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dβ3 | – | – | – | – |
| Dα5/Dα3/Dβ1 | – | – | – | – |
| Dα5/Dα3/Dβ2 | – | – | – | – |
| Dα5/Dα3/Dβ3 | – | – | – | – |
| Dα5/Dα4/Dβ1 | – | – | – | – |
| Dα5/Dα4/Dβ2 | – | – | – | – |
| Dα5/Dα4/Dβ3 | – | – | – | – |
| Dα5/Dα6/Dα7 | – | – | – | – |
| Dα5/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dβ1/Dβ3 | – | – | – | – |
| Dα5/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα2/Dβ1 | – | – | – | – |
| Dα5/Dα1/Dα2/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα3/Dβ1 | – | – | – | – |
| Dα5/Dα1/Dα3/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα3/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα4/Dβ1 | – | – | – | – |
| Dα5/Dα1/Dα4/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα4/Dβ3 | – | – | – | – |
| Dα5/Dα2/Dα3/Dβ1 | – | – | – | – |
| Dα5/Dα2/Dα3/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dα3/Dβ3 | – | – | – | – |
| Dα5/Dα2/Dα4/Dβ1 | – | – | – | – |
| Dα5/Dα2/Dα4/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dα4/Dβ3 | – | – | – | – |
| Dα5/Dα3/Dα4/Dβ1 | – | – | – | – |
| Dα5/Dα3/Dα4/Dβ2 | – | – | – | – |
| Dα5/Dα3/Dα4/Dβ3 | – | – | – | – |
| Dα5/Dα6/Dα7/Dβ1 | – | – | – | – |
| Dα5/Dα6/Dα7/Dβ2 | – | – | – | – |
| Dα5/Dα6/Dα7/Dβ3 | – | – | – | – |
| Dα5/Dβ1/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dβ1 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα2/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα3/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα4/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dα3/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dα4/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα3/Dα4/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα2/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα3/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα4/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dβ1/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα2/Dα3/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dα4/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα2/Dβ1/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα3/Dα4/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα3/Dβ1/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dα4/Dβ1 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dα4/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dα4/Dβ3 | – | – | – | – |
| Dα5/Dα6/Dα7/Dβ1/Dβ2/Dβ3 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dα4/Dα6/Dα7/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dα4/Dα6/Dα7/Dβ1/Dβ2 | – | – | – | – |
| Dα5/Dα1/Dα2/Dα3/Dα4/Dα6/Dα7/Dβ1/Dβ2/Dβ3 | – | – | – | – |
To illustrate the extent of radioligand binding studies undertaken, the Table lists all subunit combinations containing Dα5 that were examined in transfected Drosophila S2 cells. Binding studies were performed with [125I]-α-bungarotoxin (10 nM) and [3 H]-epibatidine (30 nM). Combinations of Drosophila nAChR subunit cDNAs were transfected in the absence or presence of RIC-3 cDNA. Data indicating presence or absence of specific binding are derived from at least 3 independent experiments.
Figure 1Radioligand binding to nAChR subunit chimeras expressed in S2 cells. Cell surface [125I]-α-bungarotoxin binding to transiently transfected Drosophila S2 cells with subunit chimeras (Dα5/5HT3A, Dα6/5HT3A and Dα7/5HT3A). Experiments were performed in triplicate and are means ± SEM of 4–14 independent experiments.
Figure 2Radioligand binding to nAChR subunit combinations in cultured cell lines. Cell surface [125I]-α-bungarotoxin binding to cell lines transiently transfected with combinations of Dα5, Dα6 and Dα7 subunits. In all cases, subunit combinations were co-transfected with either CeRIC-3 (filled bars) or DmRIC-3 (open bars). No specific binding was detected for any subunit combination in the absence of RIC-3 (not shown). Data are presented for Drosophila S2 cells (A) and for human tsA201 cells cultured at 25 °C (B). Controls represent mock-transfected cells. Experiments were performed in triplicate and are means ± SEM of 5–8 independent experiments.
Figure 3Functional expression of nAChR subunit combinations in oocytes. A) Dose–response curves for acetylcholine are shown for homomeric Dα5 nAChRs (open circles) homomeric Dα7 nAChRs (open squares) and for triplet Dα5 + Dα6 + Dα7 nAChRs (closed circles). B) Dose–response curves for acetylcholine are shown for heteromeric Dα5 + Dα6 nAChRs (open circles) and Dα5 + Dα7 nAChRs (closed circles) In all cases, nAChR subunits were co-expressed with CeRIC-3. Data are means ± SEM of 3–8 independent experiments.
Functional properties of recombinant nAChRs expressed in oocytes
| Dα5 | 8.8 ± 2.5 μM | 1.1 ± 0.3 | 6 | 200 [141 ± 25] |
| Dα6 | – | – | ‡ | – |
| Dα7 | 6.7 ± 1.7 μM | 1.0 ± 0.3 | 4 | 86 [45 ± 13] |
| Dα5 + Dα6 | 8.6 ± 2.4 μM | 1.0 ± 0.1 | 5 | 47 [20 ± 8] |
| Dα5 + Dα7 | 1.6 ± 0.3 μM | 1.0 ± 0.1 | 3 | 53 [39 ± 8] |
| Dα6 + Dα7 | – | – | ‡ | – |
| Dα5 + Dα6 + Dα7 | 13.5 ± 1.7 nM* | 1.2 ± 0.3 | 6 | 150 [107 ± 12] |
Note, in all cases, nAChR subunits were co-expressed with CeRIC-3.
* Note, EC50 value for Dα5 + Dα6 + Dα7 is expressed as nM, rather than μM.
**EC50 and Hill slopes are means ± SEM of separate fits to dose–response curves derived from independent experiments (n = 3–6).
† Relatively small currents were detected with all subunit combinations, as indicated by the size of the maximum current that was detected with each subunit combination (Imax) and the mean maximum current (Imean) from between 6–20 different oocytes.
‡ Subunit combinations that failed to generate functional responses are indicated by a dash. This is based on studies conducted with at least 5 batches of oocytes that generated functional nAChRs with other subunit combinations and at least 10 oocytes from each batch (n > 50).
Figure 4Antagonism of Dα5 nAChRs by α-bungarotoxin. A) Representative responses to acetylcholine (100 μM; black bar) are shown (left), together with block after a 10 min pre-incubation with α-bungarotoxin (100 nM; grey bar) (middle). Recovery from α-bungarotoxin block after 10 minutes is also illustrated (right). Data shown are for homomeric Dα5 nAChRs (co-expressed with CeRIC-3) but the results (complete block with full recovery) were observed for all subunit combinations that generated functional nAChRs (see Table 2). B) Data indicating the time course for recovery after a 10 min incubation with α-bungarotoxin (100 nM; illustrated by the grey bar). Data points are normalised to the maximum response prior to block by α-bungarotoxin and are means ± SEM of 3 independent experiments.